Save your place

Sign in to WhoBought

Please try again later.

Collegium Pharmaceutical, Inc. (COLL) institutional ownership

Latest close $35.54 Jul 20, 2026
Market cap$967M 52-week range SectorHealthcare
Funds holding · Q1 2026
265
reported COLL position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
141 buyers · 124 sellers

Collegium Pharmaceutical, Inc. (COLL) price and institutional activity

Dates

Q1 2026

$0 bought by 141 investors
Invesco Ltd.Janus Henderson Group PLC +139 more
$0 sold by 124 investors
Eventide Asset Management, LLCPacer Advisors, Inc. +122 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Collegium Pharmaceutical, Inc. (COLL) institutional activity · 265

Investor Type Est. change Change Δ Own Date
Eventide Asset Management, LLC · Reduced
Change −452K Date Q1 2026
Eventide Asset Management, LLC Reduced· Q1 2026 −452K Q1 2026
Invesco Ltd. · Added
Change +417K Δ Own +35.5% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +417K +35.5% Q1 2026
Janus Henderson Group PLC · Added
Change +377K Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +377K Q1 2026
Qube Research & Technologies Ltd · Added
Change +354K Date Q1 2026
Qube Research & Technologies Ltd Added· Q1 2026 +354K Q1 2026
Millennium Management LLC · Added
Change +291K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +291K Q1 2026
Marshall Wace, LLP · Added
Change +256K Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +256K Q1 2026
American Century Companies Inc · Added
Change +254K Date Q1 2026
American Century Companies Inc Added· Q1 2026 +254K Q1 2026
Pacer Advisors, Inc. · Exited
Change −241K Δ Own −100.0% Date Q1 2026
Pacer Advisors, Inc. Exited· Q1 2026 −241K −100.0% Q1 2026
Emerald Advisers, LLC · Reduced
Change −227K Date Q1 2026
Emerald Advisers, LLC Reduced· Q1 2026 −227K Q1 2026
Two Sigma Investments, LP · Added
Change +224K Δ Own +61.2% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +224K +61.2% Q1 2026
Rubric Capital Management LP · Reduced
Change −217K Date Q1 2026
Rubric Capital Management LP Reduced· Q1 2026 −217K Q1 2026
Assenagon Asset Management S.A. · Reduced
Change −199K Date Q1 2026
Assenagon Asset Management S.A. Reduced· Q1 2026 −199K Q1 2026
Jane Street Group, LLC · Exited
Change −191K Δ Own −100.0% Date Q1 2026
Jane Street Group, LLC Exited· Q1 2026 −191K −100.0% Q1 2026
Morgan Stanley · Reduced
Change −169K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −169K Q1 2026
Victory Capital Management Inc · Added
Change +168K Date Q1 2026
Victory Capital Management Inc Added· Q1 2026 +168K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 265

Famous investor activity in Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical, Inc. (COLL) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Santini Gino · Director 2 operations 0
Price $16.49 Owned 0 Trade date Jun 8, 2026 Filed date Jun 10, 2026
Santini Gino Director 2 operations $16.49 0 0 Jun 8, 2026 Jun 10, 2026
Freund John Gordon · Director Sell −$681
Price $34.05 Qty −20 Owned 84K Trade date May 18, 2026 Filed date May 20, 2026
Freund John Gordon Director Sell $34.05 −20 −$681 84K May 18, 2026 May 20, 2026
Freund John Gordon · Director Sell −$143K
Price $34.54 Qty −4K Owned 84K Trade date May 15, 2026 Filed date May 18, 2026
Freund John Gordon Director Sell $34.54 −4K −$143K 84K May 15, 2026 May 18, 2026
Freund John Gordon · Director 2 operations 0
Price $16.49 Owned 0 Trade date May 15, 2026 Filed date May 18, 2026
Freund John Gordon Director 2 operations $16.49 0 0 May 15, 2026 May 18, 2026
Lurker Nancy · Director Grant (A) 9K
Owned 27K Trade date May 14, 2026 Filed date May 18, 2026
Lurker Nancy Director Grant (A) 9K 27K May 14, 2026 May 18, 2026
Paya Carlos V · Director Grant (A) 9K
Owned 28K Trade date May 14, 2026 Filed date May 18, 2026
Paya Carlos V Director Grant (A) 9K 28K May 14, 2026 May 18, 2026
Freund John Gordon · Director Grant (A) 9K
Owned 79K Trade date May 14, 2026 Filed date May 18, 2026
Freund John Gordon Director Grant (A) 9K 79K May 14, 2026 May 18, 2026
Glancy Donovan Michael · Director Grant (A) 17K
Owned 17K Trade date May 14, 2026 Filed date May 18, 2026
Glancy Donovan Michael Director Grant (A) 17K 17K May 14, 2026 May 18, 2026
Bohlin Garen G. · Director Grant (A) 9K
Owned 71K Trade date May 14, 2026 Filed date May 18, 2026
Bohlin Garen G. Director Grant (A) 9K 71K May 14, 2026 May 18, 2026
Balice-Gordon Rita J. · Director Grant (A) 9K
Owned 61K Trade date May 14, 2026 Filed date May 18, 2026
Balice-Gordon Rita J. Director Grant (A) 9K 61K May 14, 2026 May 18, 2026
Santini Gino · Director Grant (A) 9K
Owned 104K Trade date May 14, 2026 Filed date May 18, 2026
Santini Gino Director Grant (A) 9K 104K May 14, 2026 May 18, 2026
Lurker Nancy · Director Sell −$162K
Price $35.97 Qty −4K Owned 18K Trade date May 13, 2026 Filed date May 15, 2026
Lurker Nancy Director Sell $35.97 −4K −$162K 18K May 13, 2026 May 15, 2026
Bohlin Garen G. · Director Sell −$323K
Price $37.18 Qty −9K Owned 62K Trade date May 11, 2026 Filed date May 13, 2026
Bohlin Garen G. Director Sell $37.18 −9K −$323K 62K May 11, 2026 May 13, 2026
Bohlin Garen G. · Director 2 operations 0
Price $16.49 Owned 0 Trade date May 11, 2026 Filed date May 13, 2026
Bohlin Garen G. Director 2 operations $16.49 0 0 May 11, 2026 May 13, 2026
Dieter David · Officer Sell −$488K
Price $34.92 Qty −14K Owned 77K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Dieter David Officer Sell $34.92 −14K −$488K 77K Mar 18, 2026 Mar 20, 2026
15 of 44
15 of 44 Sign in to continue to older insider transactions.

Collegium Pharmaceutical, Inc. (COLL) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 5.8M
% of shares outstanding 17.7% Filing date Jan 19, 2024
BlackRock Inc. 5.8M 17.7% Jan 19, 2024
Eventide Asset Management, LLC 2.6M
% of shares outstanding 8.1% Filing date Feb 14, 2024
Eventide Asset Management, LLC 2.6M 8.1% Feb 14, 2024
Vanguard Group Inc 2.3M
% of shares outstanding 7.1% Filing date Feb 13, 2024
Vanguard Group Inc 2.3M 7.1% Feb 13, 2024
Janus Henderson Group PLC 1.8M
% of shares outstanding 5.8% Filing date May 15, 2026
Janus Henderson Group PLC 1.8M 5.8% May 15, 2026
Invesco Ltd. 1.6M
% of shares outstanding 5.0% Filing date May 8, 2026
Invesco Ltd. 1.6M 5.0% May 8, 2026
Integrated Core Strategies (us) LLC 1.5M
% of shares outstanding 4.7% Filing date May 12, 2026
Integrated Core Strategies (us) LLC 1.5M 4.7% May 12, 2026
Renaissance Technologies LLC 1.5M
% of shares outstanding 4.5% Filing date May 14, 2026
Renaissance Technologies LLC 1.5M 4.5% May 14, 2026
Eventide Asset Management, LLC 1.4M
% of shares outstanding 4.5% Filing date May 15, 2026
Eventide Asset Management, LLC 1.4M 4.5% May 15, 2026
8 of 12

Collegium Pharmaceutical, Inc. (COLL) ownership FAQ

Who owns COLL?

265 reporting institutions disclosed COLL position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.